The primary prevention of Hepatitis C among injecting drug users (25th February 2009)
The findings in this report conclude that a single intervention may not, alone, be sufficient to prevent the spread of the hepatitis C virus (HCV). The evidence suggests that a combination of Opiate Substitution Therapy (OST) and the provision of Needle and Syringe Programmes (NSP) may be the most effective way of reducing HCV incidence among active injecting drug users (IDU).
This report from the Advisory Council on the Misuse of Drugs, is being published concurrently with and complementary to public health guidance from the National Institute for Health and Clinical Excellence (NICE) on Needle and Syringe programmes: providing people who inject drugs with injecting equipment.
Report
The findings in this report conclude that a single intervention may not, alone, be sufficient to prevent the spread of the hepatitis C virus (HCV). The evidence suggests that a combination of Opiate Substitution Therapy (OST) and the provision of Needle and Syringe Programmes (NSP) may be the most effective way of reducing HCV incidence among active injecting drug users (IDU).
This report from the Advisory Council on the Misuse of Drugs, is being published concurrently with and complementary to public health guidance from the National Institute for Health and Clinical Excellence (NICE) on Needle and Syringe programmes: providing people who inject drugs with injecting equipment.
Report
No comments:
Post a Comment